Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
IEC TR 62781, published in 2012 as a Technical Report, provides comprehensive guidance on the field characterization of focused ultrasonic transducers. These transducers are widely used in medical diagnostics, therapeutic ultrasound (including High-Intensity Focused Ultrasound or HIFU), non-destructive testing, and industrial processing. The ability to accurately characterize the acoustic field produced by a focused transducer is critical for ensuring treatment efficacy, safety, and reproducibility in medical applications, as well as process control in industrial settings.
The standard addresses the fundamental challenge that focused transducers produce complex three-dimensional pressure fields with steep spatial gradients near the focal region. Unlike plane-wave or weakly focused fields, the pressure distribution in a tightly focused field varies significantly over distances comparable to the acoustic wavelength, requiring careful measurement strategies and appropriate spatial sampling. This technical report consolidates best practices from research laboratories and manufacturing quality assurance programs worldwide, providing a unified framework for characterizing focused fields across frequencies ranging from 0.5 MHz to 20 MHz and focal gains from 2 to over 100.
The report defines several key parameters for characterizing focused fields. The focal length is defined as the distance from the transducer face to the point of maximum temporal-peak pressure along the acoustic axis. The focal zone is the volume within which the pressure amplitude exceeds a specified fraction (typically 50% or -6 dB) of the peak value. The depth of focus corresponds to the axial length of this focal zone. Beam width measurements are typically reported at the -3 dB, -6 dB, and -20 dB levels relative to the peak intensity, providing a comprehensive description of the focal region shape and energy distribution.
Hydrophone measurements form the backbone of field characterization. The standard recommends using membrane hydrophones or needle hydrophones with an active element diameter no larger than 0.5 mm for measurements above 1 MHz, ensuring adequate spatial resolution to resolve the fine structure of the focused field. For accurate measurements in the focal region, the hydrophone must be scanned in three dimensions with step sizes no larger than one-quarter of the acoustic wavelength at the operating frequency. This requirement means that a 3 MHz transducer requires scan steps of approximately 0.125 mm or smaller to adequately sample the field structure.
Pressure-field mapping is performed using automated scanning systems that record the pressure waveform at each spatial position. From these measurements, multiple parameters are derived: peak-positive pressure (p+), peak-negative pressure (p-), pulse intensity integral (PII), and mechanical index (MI). For therapeutic applications, the report emphasizes the importance of derating these measurements to account for tissue attenuation, typically using a derating factor of 0.3 dB/(MHz.cm) for soft tissue, which can reduce the in-situ pressure by 30-50% compared to water measurements at typical treatment depths.
| Parameter | Symbol | Definition | Typical Range (Therapeutic) |
|---|---|---|---|
| Focal length | zf | Distance to peak pressure along axis | 30-150 mm |
| Focal gain | G | Intensity ratio focused/unfocused | 10-10,000 |
| -6 dB beam width | d-6 | Lateral width at half-maximum pressure | 0.5-10 mm |
| Depth of focus | L-6 | Axial length of -6 dB focal zone | 2-80 mm |
| Peak rarefactional pressure | p- | Maximum negative pressure | 0.5-20 MPa |
| Pulse intensity integral | PII | Time-integrated intensity per pulse | 0.01-100 J/cm2 |
| Mechanical index | MI | p- / sqrt(f) for cavitation safety | 0.1-5.0 |
A critical aspect of focused field characterization is the distinction between linear and nonlinear propagation regimes. At the high pressures used in therapeutic ultrasound, nonlinear propagation can significantly distort the waveform, generating higher harmonics and causing shock formation. The report provides guidance on identifying and quantifying nonlinear effects through harmonic analysis of the measured pressure waveforms. In strongly focused fields with peak pressures above 5 MPa, the second harmonic component can reach 20-30% of the fundamental amplitude, fundamentally altering the spatial distribution of energy absorption in tissue and requiring careful consideration in treatment planning algorithms.
From an engineering perspective, the design of focused transducers involves balancing multiple competing requirements. The aperture size and radius of curvature determine the focal gain and depth of focus: a larger aperture with a shorter radius of curvature produces a tighter focus with higher gain but reduced depth of focus. For medical applications requiring precise targeting of small tumors (1-3 cm diameter), F-numbers (focal length/aperture diameter) of 0.8 to 1.2 are commonly used, providing a good balance between focal sharpness and working distance.
The choice of operating frequency involves a fundamental trade-off between spatial resolution and penetration depth. Higher frequencies produce tighter focal zones but suffer from greater attenuation in tissue. At 1 MHz, attenuation limits penetrating depth to approximately 10-15 cm for therapeutic applications, while at 5 MHz, useful penetration is typically limited to 3-5 cm. Multi-element phased-array transducers offer the ability to electronically steer and shape the focal zone, providing dynamic compensation for tissue inhomogeneities through adaptive focusing techniques. These arrays require individual channel calibration and field characterization per IEC TR 62781 guidelines to ensure that the combined field from all elements produces the intended pressure distribution.
The standard also addresses measurement uncertainty, which is particularly important for clinical applications. The combined uncertainty in determining the peak rarefactional pressure at the focus is typically 15-25%, with major contributions from hydrophone calibration uncertainty (10-15%), positioning accuracy (5-10%), and waveform digitization (3-5%). Engineers designing quality assurance protocols must establish measurement procedures that achieve a target expanded uncertainty (k=2) of no more than 30% for therapeutic beam characterization, with more stringent requirements of 20% for diagnostic applications where safety indices depend on accurate pressure determination.
| Frequency Range | Hydrophone Type | Active Element Diameter | Max. Step Size | Typical Application |
|---|---|---|---|---|
| 0.5-2 MHz | Membrane or needle | 0.2-0.5 mm | 0.2 mm | HIFU therapy |
| 2-8 MHz | Membrane | 0.1-0.2 mm | 0.1 mm | Physiotherapy, diagnostics |
| 8-20 MHz | Membrane, PVDF | 0.04-0.1 mm | 0.05 mm | High-resolution imaging |